相关实验视频

Updated: May 12, 2025

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

声学激活的纳米平台通过加剧瘤缺氧来实现瘤回归

Caixia Ling^1,2, Shanshan Ma^1,3, Mengqi Zhang^1,3

¹Department of Ultrasound and Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, China.

Journal of cancer research and therapeutics

|May 3, 2025

概括

这项研究引入了新的纳米粒子,通过阻断血液供应和增强缺氧,使癌细胞饿死. 这种综合方法显示了有效的癌症治疗与良好的生物相容性显著的希望.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
在瘤学瘤学.

背景情况:

癌症饥饿疗法旨在通过阻断营养和氧气供应来抑制瘤生长.
缺氧会加剧癌症的进展,这对有效治疗构成了挑战.
开发克服缺氧的策略对于增强癌症饥饿治疗至关重要.

研究的目的:

开发一个多路径纳米平台,以改善缺氧加剧的癌症饥饿治疗.
将一个声敏器 (IR780) 和一个血管干扰器 (vadimezan,DMXAA) 共同装入树突性二氧化纳米载体.
创建适应酸的纳米平台 (DMXAA/IR780@SiO2,DIS NPs) 以提供有针对性的药物和增强治疗效果.

主要方法:

使用一合成方法创建了DMXAA/IR780@SiO2 (DIS NPs).
为了评估抗瘤机制,进行了体外和体内实验.
研究了纳米平台的酸反应降解,药物释放和协同治疗效应.

主要成果:

DIS NPs在酸性瘤微环境中降解,释放DMXAA以破坏瘤血管并阻断营养/氧气供应.
在超声波 (US) 照射下释放的IR780产生了反应性氧物种,进一步诱导缺氧并损害线粒体.
与DIS NPs和US的联合治疗在体内表现出显著的协同抗瘤效应,具有良好的生物安全性.

结论:

开发的DIS NPs为缺氧加剧的癌症饥饿治疗提供了一个有希望的策略.
这种方法为癌症治疗提供了潜在的新途径,证明了疗效和生物相容性.
血管干扰和增强缺氧的协同效应显示出改善瘤结果的潜力.

关键词:

有反应性氧物种的反应性氧物种.声动力学疗法声动力学疗法饥饿疗法是一种治疗方法.瘤微环境是一个微环境.血管破坏剂血管破坏剂

更多相关视频

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...